Valuation: Glycorex Transplantation AB

Market Cap 116M 11.64M 10.41M 9.63M 8.72M 16.32M 1.11B 16.59M 45.85M 579M 43.7M 42.77M 1.83B P/E 2024
-13.8x
P/E 2025 -16.1x
Enterprise Value 112M 11.22M 10.04M 9.29M 8.41M 15.74M 1.07B 15.99M 44.2M 559M 42.13M 41.23M 1.77B EV / Sales 2024
4.29x
EV / Sales 2025 3.12x
Free-Float
95.86%
Yield 2024 *
-
Yield 2025 -
1 day-2.97%
1 week-2.65%
Current month-0.68%
1 month+20.49%
3 months-11.98%
6 months+17.60%
Current year-7.55%
1 week 1.47
Extreme 1.47
1.6
1 month 1.16
Extreme 1.16
1.62
Current year 1.12
Extreme 1.125
1.77
1 year 1.12
Extreme 1.125
1.93
3 years 0.76
Extreme 0.764
4.09
5 years 0.76
Extreme 0.764
10.04
10 years 0.76
Extreme 0.764
19.25
Manager TitleAgeSince
Chief Executive Officer 41 31/08/2013
Comptroller/Controller/Auditor - -
Sales & Marketing - 31/03/2022
Director TitleAgeSince
Director/Board Member 57 31/12/2022
Director/Board Member 38 31/12/2022
Director/Board Member 66 31/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
24/02/22 Buy

Chief Executive Officer

100,000 0.1417%
20/05/21 Buy

Director

15,000 0.0213%
15/04/21 Buy

Director

10,000 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-2.97%-2.65%-20.33%+24.58% 11.64M
+0.88%-0.34%+40.64%+73.05% 65.28B
-0.33%-0.36%+9.40%+76.84% 54.57B
-0.68%+1.25%+9.37%+101.14% 53.59B
-2.06%+2.90%+24.07%+48.36% 45.03B
-1.79%+0.19%+19.32%+123.62% 42.17B
-1.65%+0.96%+237.56%+823.66% 39.42B
-2.26%-4.14%+15.38%+45.53% 32.71B
-2.70%-10.77%+19.80%-6.47% 24.01B
+0.29%+14.41%+59.20%+48.33% 26.5B
Average -1.33%+2.08%+41.44%+135.86% 38.33B
Weighted average by Cap. -0.95%+2.27%+45.60%+148.33%

Financials

2024 2025
Net sales 35.16M 3.53M 3.16M 2.92M 2.65M 4.95M 336M 5.03M 13.91M 176M 13.26M 12.97M 556M 38.84M 3.9M 3.49M 3.23M 2.92M 5.47M 371M 5.56M 15.37M 194M 14.64M 14.33M 615M
Net income -10.94M -1.1M -983K -909K -823K -1.54M -105M -1.57M -4.33M -54.69M -4.12M -4.04M -173M -7.72M -775K -693K -642K -581K -1.09M -73.78M -1.1M -3.05M -38.59M -2.91M -2.85M -122M
Net Debt 229K 23K 20.57K 19.03K 17.23K 32.25K 2.19M 32.78K 90.58K 1.14M 86.33K 84.49K 3.62M -4.17M -419K -375K -347K -314K -587K -39.86M -597K -1.65M -20.85M -1.57M -1.54M -66.01M
Projected Income Statement - Annual - Glycorex Transplantation AB
Logo Glycorex Transplantation AB
Glycorex Transplantation AB (publ) is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. The Company’s medical devices enable transplants across the blood groups saving lives and providing health economic benefits by increasing the number of transplants.
Employees
20
Date Price Change Volume
26/10/26 SEK 1.470 -2.97% 67,332
23/10/26 SEK 1.515 -5.31% 5,145
22/10/26 SEK 1.600 +4.23% 4,218
21/10/26 SEK 1.535 +3.72% 41,596
20/10/26 SEK 1.480 -1.99% 6,666
  1. Stock Market
  2. Stocks
  3. GTAB B Stock